News

1 Feb 2018
Roger Wilson on the challenges of being a cancer survivor

1 Feb 2018
Investing in the future leaders of oncology

1 Feb 2018
Interview with Jean-Jacques Stelmes, a fellow at EORTC HQ

26 Jan 2018
Why does cancer survivorship matter?

8 Jan 2018
Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy in Patients with Stage 3 Resected High-Risk Melanoma (EORTC1325/KEYNOTE-054)

8 Dec 2017
Largest trial ever performed in alveolar soft part sarcoma: results published

7 Dec 2017
EORTC presents at ASH Annual Meeting & Exposition 2017

4 Dec 2017
EORTC presents at San Antonio Breast Cancer Symposium

23 Nov 2017
Surviving cancer: what is the future?


